- Home
- ARMP vs OSTX Comparison
ARMP vs OSTX Comparison
Compare ARMP & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- OSTX
- Stock Information
- Founded
- ARMP N/A
- OSTX 2018
- Country
- ARMP United States
- OSTX United States
- Employees
- ARMP N/A
- OSTX N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- OSTX
- Sector
- ARMP Health Care
- OSTX
- Exchange
- ARMP Nasdaq
- OSTX NYSE
- Market Cap
- ARMP 52.1M
- OSTX 43.0M
- IPO Year
- ARMP N/A
- OSTX 2024
- Fundamental
- Price
- ARMP $1.91
- OSTX $1.81
- Analyst Decision
- ARMP Strong Buy
- OSTX Strong Buy
- Analyst Count
- ARMP 1
- OSTX 3
- Target Price
- ARMP $9.00
- OSTX $18.00
- AVG Volume (30 Days)
- ARMP 36.4K
- OSTX 302.3K
- Earning Date
- ARMP 08-12-2025
- OSTX 08-14-2025
- Dividend Yield
- ARMP N/A
- OSTX N/A
- EPS Growth
- ARMP N/A
- OSTX N/A
- EPS
- ARMP N/A
- OSTX N/A
- Revenue
- ARMP $4,699,000.00
- OSTX N/A
- Revenue This Year
- ARMP $8.43
- OSTX N/A
- Revenue Next Year
- ARMP N/A
- OSTX N/A
- P/E Ratio
- ARMP N/A
- OSTX N/A
- Revenue Growth
- ARMP 14.24
- OSTX N/A
- 52 Week Low
- ARMP $0.90
- OSTX $1.12
- 52 Week High
- ARMP $3.42
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- ARMP 52.83
- OSTX N/A
- Support Level
- ARMP $1.74
- OSTX N/A
- Resistance Level
- ARMP $2.00
- OSTX N/A
- Average True Range (ATR)
- ARMP 0.15
- OSTX 0.00
- MACD
- ARMP -0.03
- OSTX 0.00
- Stochastic Oscillator
- ARMP 43.59
- OSTX 0.00
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.